EUVIMEDEUVIMED entdecken
Crossref

The cost‐effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030

Yinzong Xiao, Margaret E Hellard iD, Alexander J Thompson, Christopher Seaman, Jess Howell, Nick Scott

Medical Journal of Australia · 2023

DOI: 10.5694/mja2.51825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Journal of Australia, 2023. Verfasst von Yinzong Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Burnet Institute, Melbourne, VIC. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Australian Government Research Training Program scholarship, Australian National Health and Medical Research Council, Victorian Operational Infrastructure Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis BHumansAntiviral AgentsCost-Benefit AnalysisMass ScreeningHepatitis B virusQuality-Adjusted Life YearsWorld Health Organization

Stichwörter der Autor:innen

Economics, medicalHepatitis BMass screeningPublic health

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • The Burnet Institute, Melbourne, VIC.
  • The Alfred Hospital, Melbourne, VIC.
  • St Vincent's Hospital, Melbourne, VIC.
  • The University of Melbourne, Melbourne, VIC.
  • Monash University, Melbourne, VIC.

ORCID-Profile: Margaret E Hellard

Förderung

  • Australian Government Research Training Program scholarship
  • Australian National Health and Medical Research Council
  • Victorian Operational Infrastructure Support Program

Zitieren

APA

Xiao, Y., Hellard, M. E., Thompson, A. J., Seaman, C., Howell, J., & Scott, N. (2023). The cost‐effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030. Medical Journal of Australia. https://doi.org/10.5694/mja2.51825

Vancouver

Xiao Y, Hellard ME, Thompson AJ, Seaman C, Howell J, Scott N. The cost‐effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030. Medical Journal of Australia. 2023. doi:10.5694/mja2.51825

BibTeX
@article{Xiao2023,
  author = {Xiao, Yinzong and Hellard, Margaret E and Thompson, Alexander J and Seaman, Christopher and Howell, Jess and Scott, Nick},
  title = {The cost‐effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030},
  journal = {Medical Journal of Australia},
  year = {2023},
  doi = {10.5694/mja2.51825}
}
Kostenlos starten →